Cardiovasc Prev Pharmacother.  2021 Oct;3(4):124-133. 10.36011/cpp.2021.3.e16.

Association between Myocardial Infarction Location and In-Hospital Mortality in Iran: A Nationwide Study

• Shahbaz M
• Nazari SSH
• Salehipour A
• Karimi R

• KMID: 2536939
• DOI: http://doi.org/10.36011/cpp.2021.3.e16

Abstract

Background
Myocardial infarction (MI) is one of the most important health problems in the world, including Iran. The rate of in-hospital mortality in MI patients ranges from 7.7% to 19.2% in different countries. Despite the promotion and utilization of new therapeutic approaches, MI-related morbidity and mortality have remained high . The recognition of risk factors for MI-related mortality plays an important role in reducing post-MI mortality.
Methods
In this study, we used national MI registry data. In total, 33,831 patients who had been hospitalized in the coronary care unit of Iranian hospitals from 2012 to 2014 were analyzed. Using multivariable logistic regression, we estimated the impact of various risk factors on in-hospital mortality after MI.
Results
The in-hospital mortality rate in patients with ST-elevation MI was higher than that of patients with non–ST-elevation MI. In-hospital mortality was most strongly associated with left-location MI (odds ratio [OR] relative to the non-ST-elevation MI group, 2.15), in comparison with middle-location MI (OR, 1.47) and right-location MI (OR, 1.43). Ventricular fibrillation (OR, 7.7) and ventricular tachycardia (OR, 2.78) were predictors of in-hospital mortality. Receiving treatment reduced the odds of death and age, sex, and diabetes were risk factors associated with in-hospital mortality after MI.
Conclusions
Age, sex, right bundle branch block arrhythmia, atrial fibrillation, ventricular tachycardia, left bundle branch block arrhythmia, ventricular fibrillation, dyspnea, diabetes, and ST-elevation MI were associated with increased ORs for mortality after MI. Thus, patients with these factors require special attention during hospitalization.

Keyword

Myocardial infarction; Hospital mortality; Ventricular fibrillation

Reference

1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization;2011.

2. Ahmadi A, Etemad K, Ahmadi S, Khaledifard A. Current status of myocardial infarction and risk factors for associated mortality in Iran: a review. J Epidemiol Public Health Rev. 2016; 1:1–5.

3. Stevens B, Verdian L, Pezzullo L, Tomlinson J, Nugent J. The economic burden of myocardial infarction in Latin America. Value Health. 2016; 19:A646.

4. Roger VL, Jacobsen SJ, Weston SA, Goraya TY, Killian J, Reeder GS, Kottke TE, Yawn BP, Frye RL. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med. 2002; 136:341–8.

5. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2014 update: a report from the American Heart Association. Circulation. 2014; 129:e28–292.

6. Ahmadi A, Soori H, Mehrabi Y, Etemad K, Samavat T, Khaledifar A. Incidence of acute myocardial infarction in Islamic Republic of Iran: a study using national registry data in 2012. East Mediterr Health J. 2015; 21:5–12.

7. Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson J. Harrison’s principles of internal medicine. 2nd ed. New York, NY: McGraw Hill Medical Publishing Division;2005.

8. Mann D, Zipes D, Libby P, Bonow R. Braunwald's heart disease: a textbook of cardiovascular medicine. 10th ed. Philadelphia, PA: Elsevier Health Sciences;2014.

9. Hreybe H, Saba S. Location of acute myocardial infarction and associated arrhythmias and outcome. Clin Cardiol. 2009; 32:274–7.

10. Shi G, Chen K, Zhang T, Li Y, Zhang Y. Terminal QRS distortion versus serum levels of brain natriuretic peptide: Association with clinical prognosis in acute myocardial infarction. Life Sci J. 2014; 11:744–50.

11. Timoteo AT, Ramos R, Toste A, Lousinha A, Oliveira JA, Ferreira ML, Cruz Ferreira R. [Impact of age on treatment and outcomes after acute myocardial infarction, particularly in very elderly patients]. Rev Port Cardiol. 2011; 30:897–903. Portuguese.

12. Ranjbar S, Karvandi M, Hassantash SA, Foroughi M. How to construct a 3D mathematical/computer model of the left ventricle. Arch Cardiovasc Imaging. 2014; 2:e20628.

13. Peltonen M, Lundberg V, Huhtasaari F, Asplund K. Marked improvement in survival after acute myocardial infarction in middle-aged men but not in women. The Northern Sweden MONICA study 1985-94. J Intern Med. 2000; 247:579–87.

14. Wang J, Yu W, Zhao D, Liu N, Yu Y. In-hospital and long-term mortality in 35,173 Chinese patients undergoing coronary artery bypass grafting in Beijing: impact of sex, age, myocardial infarction, and cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2017; 31:26–31.

15. Mansoor H, Elgendy IY, Segal R, Bavry AA, Bian J. Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: a machine learning approach. Heart Lung. 2017; 46:405–11.

16. Hosseini SK, Soleimani A, Karimi AA, Sadeghian S, Darabian S, Abbasi SH, Ahmadi SH, Zoroufian A, Mahmoodian M, Abbasi A. Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age. Monaldi Arch Chest Dis. 2009; 72:71–6.

17. Sozzi FB, Danzi GB, Foco L, Ferlini M, Tubaro M, Galli M, Celli P, Mannucci PM. Myocardial infarction in the young: a sex-based comparison. Coron Artery Dis. 2007; 18:429–31.

18. Ravn-Fischer A, Karlsson T, Santos M, Bergman B, Herlitz J, Johanson P. Inequalities in the early treatment of women and men with acute chest pain? Am J Emerg Med. 2012; 30:1515–21.

19. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, Gieseler U, Voigtlander T, Hauptmann KE, Wagner S, Senges J. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol. 2002; 89:511–7.

20. Medina HM, Cannon CP, Fonarow GC, Grau-Sepulveda MV, Hernandez AF, Frank Peacock W, Laskey W, Peterson ED, Schwamm L, Bhatt DL; GWTG Steering Committee and Investigators. Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease. Clin Cardiol. 2012; 35:632–40.

21. Kim KH, Jeong MH, Ahn Y, Kim YJ, Cho MC, Kim W; Other Korea Acute Myocardial Infarction Registry Investigators. Differential clinical implications of high-degree atrioventricular block complicating ST-segment elevation myocardial infarction according to the location of infarction in the era of primary percutaneous coronary intervention. Korean Circ J. 2016; 46:315–23.

22. Kirchberger I, Heier M, Kuch B, von Scheidt W, Meisinger C. Presenting symptoms of myocardial infarction predict short- and long-term mortality: the MONICA/KORA Myocardial Infarction Registry. Am Heart J. 2012; 164:856–61.

23. Arnold SV, Spertus JA, Jones PG, Xiao L, Cohen DJ. The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry. Am Heart J. 2009; 157:1042–9.

24. Mathur MB, Ding P, Riddell CA, VanderWeele TJ. Web site and R package for computing E-values. Epidemiology. 2018; 29:e45–7.

25. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017; 167:268–74.